An emerging disease threat : how the U.S. is responding to COVID-19, the novel coronavirus : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixteenth Congress, second session on examining an emerging disease threat, focusing on how the United States is responding to COVID-19, the novel cornonavirus, March 3, 2020.
| Author/creator | United States |
| Format | Electronic |
| Publication | Washington : U.S. Government Publishing Office, 2021. |
| Description | 1 online resource (iii, 57 pages). |
| Supplemental Content | PDF version |
| Supplemental Content | Text version |
| Subjects |
| Portion of title | How the U.S. is responding to COVID-19, the novel coronavirus |
| Series | S. hrg. ; 116-504 United States. Congress. Senate. S. hrg. ; 116-504. ^A500722 |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references. |
| Performer | Hearing witnesses: Statement of Schuchat, Anne, M.D., Principal Deputy Director, Centers for Disease Control and Prevention, Atlanta, GA; Statement of Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Statement of Kadlec, Robert, M.D., Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC; Statement of Hahn, Stephen, M.D., Commissioner, U.S. Food and Drug Administration, Silver Spring, MD. |
| Date/time/place of a event note | Date of hearing: 2020-03-03. |
| Source of description | Description based on online resource; title from PDF title page (govinfo, viewed Dec. 15, 2021). |
| Issued in other form | Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Emerging disease threat |
| Genre/form | Legislative hearings. |
| Standard identifier# | 45-217 (GPO jacket number) |
| GPO item number | 1043-C (online) |
| Govt. docs number | Y 4.L 11/4:S.HRG.116-504 |